类风湿关节炎患者接受或抵触改善病情抗风湿药方案的动机
该定性研究访谈48例类风湿关节炎(RA)患者,分析其接受或抵触改善病情抗风湿药(DMARDs)治疗方案的内在动机。除对药物必要性与危险性的感受外,患者对患病身份、服药行为及决策过程本身的感受也是重要驱动因素。接受动机包括渴望回归正常生活和恐惧未来残疾;抵触动机包括恐惧药物、维持健康控制、否认患病身份、对治疗失望及决策认知负担过重。
要点
- 患者对药物必要性、危险性及患病身份的感受共同驱动DMARDs治疗决策。
- 接受动机主要为渴望回归正常生活与恐惧RA所致未来残疾。
- 抵触动机包括恐惧药物、维持控制、否认患病身份、治疗失望及决策负担。
核心结论
- 患者对经历和信息的感受在权衡治疗获益与代价中起主要作用,风湿科医生咨询治疗选择时关注患者感受可能很重要。
研究设计与样本
- 定性研究,共访谈48例类风湿关节炎(RA)患者,了解其DMARDs决策经历,采用叙事分析方法转录、编码并分析主题。
主要发现
- 接受治疗方案的动机有2个主题:渴望回归正常生活,以及恐惧RA导致的未来残疾。
- 抵触治疗方案的动机有5个主题:恐惧药物、维持对健康的控制、否认患病身份、对治疗失望、感觉决策认知负担过重。
- 除对药物必要性和危险性的感受外,患者对患病身份、服药行为及决策过程本身的感受也是重要驱动因素。
临床怎么用
- 风湿科医生咨询DMARDs治疗选择时,可关注并处理患者对患病身份、服药行为及决策过程的感受。
局限性
- 原文指出需进一步研究如何在整个治疗决策过程中最佳地处理患者感受。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Patient refusal of and nonadherence to treatment with disease-modifying antirheumatic drugs (DMARDs) can adversely affect disease outcomes in rheumatoid arthritis (RA). This qualitative study describes how RA patients' feelings in response to experiences and information affected their decisions to accept (agree to adopt, initiate, and implement) or resist (refuse, avoid, and discontinue) DMARD treatment regimens. METHODS: A total of 48 RA patients were interviewed about their experiences making decisions about DMARDs. The interviews were transcribed, coded, and analyzed for themes related to their internal motivations for accepting or resisting treatment regimens, using a narrative analysis approach. RESULTS: In addition to feelings about the necessity and dangers of medications, patients' feelings towards their identity as an ill person, the act of taking medication, and the decision process itself were important drivers of patient's decisions. For patients' motivations to accept treatment regimens, 2 themes emerged: a desire to return to a normal life, and fear of future disability due to RA. For motivations to resist treatment regimens, 5 themes emerged: fear of medications, maintaining control over health, denial of sick identity, disappointment with treatment, and feeling overwhelmed by the cognitive burden of deciding. CONCLUSION: Feelings in response to experiences and information played a major role in how patients weighed the benefits and costs of treatment options, suggesting that addressing patients' feelings may be important when rheumatologists counsel about therapeutic options. Further research is needed to learn how best to address patients' feelings throughout the treatment decision-making process.
引用
- Shaw Y, Metes ID, Michaud K, et al. Rheumatoid Arthritis Patients' Motivations for Accepting or Resisting Disease-Modifying Antirheumatic Drug Treatment Regimens. Arthritis Care Res (Hoboken). 2018. PMID: 28575542. doi:10.1002/acr.23301
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。